Medicines use review service in community pharmacies in Spain: REVISA project
- PDF / 611,524 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 67 Downloads / 163 Views
RESEARCH ARTICLE
Medicines use review service in community pharmacies in Spain: REVISA project Nuria García‑Agua Soler1,2,3,4 · Eugenia Gómez‑Bermúdez4 · Vicente J. Baixauli‑Fernández4 · Sara Bellver‑Beltrán4 · Javier Velasco‑Martínez4 · Antonio J. García Ruiz1,2 · Francisco Jódar‑Sánchez5 Received: 1 April 2020 / Accepted: 17 September 2020 © The Author(s) 2020
Abstract Background Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. Objective The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. Method A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient’s medicines use. Main outcome measure Medicines use review-related time and cost, satisfaction and willingness to pay. Results A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). Conclusion Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners. Keywords Adherence · Community pharmacies · Medicines use review · Polypharmacy · Willingness to pay
Impacts on practice • The medicines use review service appears to be accept-
able to patients and the most of them would be willing to pay for this service.
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s11096-020-01158-2) contains supplementary material, which is available to authorized users. * Nuria García‑Agua Soler [email protected] 1
Chair of Health Economics and Rational Use of Drugs, Department of Pharmacology. University of Málaga, Boulevard Louis Pasteur, 32, 29071 Málaga, Spain
2
Pharmacoeconomics: Clinical and Economic Evaluation of Pharmaceutical Drugs and Palliative Care, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain
3
Illustrious in the Official College of Pharmacists of Málaga, Málaga, Spain
4
Subcommittee Medicines Use Review, Spanish Society of Family and Comm
Data Loading...
